InMode Ltd - Asset Resilience Ratio
InMode Ltd (INMD) has an Asset Resilience Ratio of 14.57% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of InMode Ltd to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how InMode Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see InMode Ltd balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down InMode Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore INMD long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $104.94 Million | 14.57% |
| Total Liquid Assets | $104.94 Million | 14.57% |
Asset Resilience Insights
- Moderate Liquidity: InMode Ltd has 14.57% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
InMode Ltd Industry Peers by Asset Resilience Ratio
Compare InMode Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medtronic plc
SA:MDTC34 |
Medical Devices | 7.82% |
|
Demant A/S
CO:DEMANT |
Medical Devices | -2.59% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Biosynex
PA:ALBIO |
Medical Devices | 3.35% |
Annual Asset Resilience Ratio for InMode Ltd (2016–2025)
The table below shows the annual Asset Resilience Ratio data for InMode Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 32.98% | $252.79 Million | $766.43 Million | -23.17pp |
| 2024-12-31 | 56.15% | $441.14 Million | $785.67 Million | -13.03pp |
| 2023-12-31 | 69.18% | $597.19 Million | $863.29 Million | -0.63pp |
| 2022-12-31 | 69.81% | $449.84 Million | $644.41 Million | -2.87pp |
| 2021-12-31 | 72.67% | $347.78 Million | $478.54 Million | +7.89pp |
| 2020-12-31 | 64.78% | $191.60 Million | $295.76 Million | -3.28pp |
| 2019-12-31 | 68.06% | $148.63 Million | $218.38 Million | +22.94pp |
| 2018-12-31 | 45.13% | $36.58 Million | $81.06 Million | +26.24pp |
| 2017-12-31 | 18.88% | $7.45 Million | $39.44 Million | +9.25pp |
| 2016-12-31 | 9.63% | $1.59 Million | $16.49 Million | -- |
About InMode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous ski… Read more